Yantai Lnc Biotechnology Singapore Pte. Ltd.

This early-stage study tested the safety of a new radioactive drug called 177Lu-LNC1004 in adults with advanced solid tumors that have spread or returned. The main goal was to find the highest dose patients could tolerate without severe side effects. Researchers gave small groups…

This early-stage study is testing a new radioactive dye called 18F-LNC1007 for PET/CT scans. It aims to see how the dye moves through the body, how much radiation it delivers, and if it's safe. The study involves 8 people, including healthy volunteers and cancer patients with a v…

This early-stage study tested a new radioactive tracer called 68Ga-LNC1007, which is used for PET scans to detect cancer. It involved 8 total participants, including both healthy adults and people with solid tumors, to see if the injection was safe and to measure how it traveled …